[Hypertensive leg ulcers: epidemiological characteristics and prognostic factors for healing in a prospective cohort]

Ann Dermatol Venereol. 2012 May;139(5):346-9. doi: 10.1016/j.annder.2011.09.191. Epub 2012 Feb 1.
[Article in French]

Abstract

Background: The data concerning changes in the characteristics of hypertensive leg ulcers (HLU) were taken from open studies in a small patient cohort. The aim of this study was to describe the epidemiological characteristics and to identify prognostic factors for healing in a prospective cohort of 59 patients presenting HLU.

Patients and methods: The cohort comprised patients included in a randomized, double-blind, controlled study published elsewhere; the patients were receiving becaplermin gel (Regranex(®)) or Duoderm Hydrogel™ once daily for eight weeks for the most recent wound. Total follow-up was 12 weeks.

Results: The epidemiological analysis was performed for 59 consecutive patients randomized in 17 dermatology departments. Mean patient age was 74.5 ± 9 years and 61% were female. Mean wound duration was 11.1 ± 9 weeks and median wound area was 16 cm(2) (q1; q3: 8; 25.5). Among, 94.9% of patients had hypertension and 39.7% were diabetic. A homolateral peripheral pulse was present in 91.5% of patients. At the end of follow-up, complete wound healing was obtained in 30.5% of the patients. In univariate analysis, neither the foregoing criteria nor the treatment group were significantly associated with healing during the study.

Conclusion: This study confirms female predominance, old age, prevalence of diabetes and delay in the diagnosis of HLU. The prognosis for healing does not appear to be dependent on wound duration, wound area or the presence of moderate peripheral arterial disease, doubtless because this condition progresses by episodes of flare-up and under specific conditions.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Angiogenesis Inducing Agents / therapeutic use*
  • Becaplermin
  • Cicatrix*
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension / complications
  • Leg Ulcer / diagnosis
  • Leg Ulcer / drug therapy*
  • Leg Ulcer / epidemiology*
  • Leg Ulcer / etiology
  • Male
  • Prognosis
  • Prospective Studies
  • Proto-Oncogene Proteins c-sis / therapeutic use*
  • Remission Induction

Substances

  • Angiogenesis Inducing Agents
  • Proto-Oncogene Proteins c-sis
  • Becaplermin